Granules India Limited Strategic & Operational Analysis

Triton Laboratories Private Limited

The predecessor entity to Granules India Limited, which began operations in 1984.

Granules India Limited

A vertically integrated pharmaceutical manufacturer headquartered in Hyderabad, Telangana, incorporated in 1991 and listed on Hyderabad stock exchanges in 1995.

Healing Lives Responsibly Through Green Science

Granules India Limited's core mission statement integrating pharmaceutical manufacturing with environmental stewardship and social responsibility.

Paracetamol Global Market Share

Granules India holds a reported $30\%$ global market share in the paracetamol market.

Granules Geographic Revenue Distribution

Revenue distribution defined as $79\%$ North America, $10\%$ Europe, $5\%$ Rest of the World (ROW), $4\%$ Latin America (LATAM), and $2\%$ India (Domestic).

Bonthapally Facility

Granules India's manufacturing facility located in Hyderabad that produces Active Pharmaceutical Ingredients (APIs).

Jeedimetla Plant

Granules India's plant in Hyderabad that manufactures multiple Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs).

Gagillapur Facility

Granules India's facility focused on large-scale PFI and finished-dose manufacturing, which received an FDA warning letter in February 2025.

Chantilly Facility

Granules India's research and development and finished-dosage facility located in Chantilly, Virginia, USA, supporting oral solid drug development and commercialisation.

Installed API Capacity

Approximately $40,000\text{ tonnes}$ per year across Granules' Hyderabad and Visakhapatnam facilities.

PFI Batch Capacity

Granules India's PFI facilities support a batch capacity of around $24,640\text{ tonnes}$ per year.

Ibuprofen Tablets, USP 600 mg Label

A 50-tablet product label manufactured by Granules India Limited in Hyderabad, India, for Granules USA, Inc. Parsippany, NJ, with storage specified at $20^\circ\text{ to }25^\circ\text{C}$.

11th Water Innovation Summit 2025 Recognition

Summit event where Granules was honoured for progress towards water neutrality.

Mobile Women's Cancer Screening Unit

A mobile screening unit initiative operated in collaboration with AIG Hospitals Department of Breast Health, Gynaecology & Oncology under Granules CSR outreach.

Total Variable-Cost Benchmark

An analytical grouping totaling